Back to Awarded Treatment Trials
Awarded Trial: 05T-678
200 mg t.i.d.
Secondary Drug Intervention
Duration of Study Period for Each Subject
PANSS, BPRS, CGI, BDIS, Quality of life scale, SAS
Twenty-nine (29) individuals with acute schizophrenia were randomized to cannabidiol 600 mg/d or placebo for 14 days, then crossed over to the other treatment for 14 days. Assessments were done with BPRS, PANSS, CGI, HAM-A, and CDSS. Individuals on cannabidiol showed greater improvement, but it did not achieve statistical significance.
Department of Psychiatry and Psychotherapy
Klinikum der Unversitaet zu Koeln
Kerpener Str. 62
City or Town
State or Province
Zip or Postal Code